On Tuesday, Legend Biotech Corp ADR (NASDAQ: LEGN) was 0.35% up from the session before settling in for the closing price of $45.30. A 52-week range for LEGN has been $38.60 – $70.13.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 50.60%. When this article was written, the company’s average yearly earnings per share was at 39.33%. With a float of $181.45 million, this company’s outstanding shares have now reached $181.91 million.
Considering the fact that the conglomerate employs 1826 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 56.67%, operating margin of -76.29%, and the pretax margin is -62.95%.
Legend Biotech Corp ADR (LEGN) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Legend Biotech Corp ADR stocks. The insider ownership of Legend Biotech Corp ADR is 0.94%, while institutional ownership is 50.05%. The most recent insider transaction that took place on Sep 25 ’24, was worth 66,326. Before that another transaction happened on Sep 20 ’24, when Company’s Officer proposed sale 90,060 for $48.91, making the entire transaction worth $4,405,003.
Legend Biotech Corp ADR (LEGN) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.34 earnings per share (EPS) during the time that was better than consensus figure (set at -0.68) by 0.34. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 39.33% per share during the next fiscal year.
Legend Biotech Corp ADR (NASDAQ: LEGN) Trading Performance Indicators
You can see what Legend Biotech Corp ADR (LEGN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 18.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.57, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -0.50 in one year’s time.
Technical Analysis of Legend Biotech Corp ADR (LEGN)
Compared to the last year’s volume of 1.06 million, its volume of 0.98 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 63.65%. Additionally, its Average True Range was 2.18.
During the past 100 days, Legend Biotech Corp ADR’s (LEGN) raw stochastic average was set at 25.30%, which indicates a significant decrease from 35.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.20% in the past 14 days, which was higher than the 48.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $49.77, while its 200-day Moving Average is $52.22. Nevertheless, the first resistance level for the watch stands at $46.05 in the near term. At $46.65, the stock is likely to face the second major resistance level. The third major resistance level sits at $47.39. If the price goes on to break the first support level at $44.71, it is likely to go to the next support level at $43.97. Should the price break the second support level, the third support level stands at $43.37.
Legend Biotech Corp ADR (NASDAQ: LEGN) Key Stats
There are 182,305K outstanding shares of the company, which has a market capitalization of 8.33 billion. As of now, sales total 285,140 K while income totals -518,250 K. Its latest quarter income was 186,520 K while its last quarter net income were -18,200 K.
